Pressure to speed up development of new therapeutics,
alongside rising R&D costs and ever-stricter regulations, has led to many companies turning to high-throughput process development methods for faster results and greater knowledge, claims Aleksandra Schenning at
GE Healthcare Life Sciences.
Aleksandra Schenning, GE Healthcare Life Sciences (March 2014)
process development, Microscale experimentation, Analytical methodology, Experimental design, Data management